StartUPDATES: New developments from healthcare startups
Check out new developments from Healthmine, Source Health, Amino Health, Nym Health, and Waltz Health.
Check out new developments from Healthmine, Source Health, Amino Health, Nym Health, and Waltz Health.
Check out new developments from Seven Bridges, Healthmine, Bright Health, and My One Medical Source.
Check out news from Equiva, Healthmine, 9am.health, Forge Health and more.
Check out new developments from Healthmine, Light Solutions Company, Zephyr AI, and more.
Check out news from Equiva, Healthmine, Recora, and Antidote Health.
Read about news from Element Science, Healthmine, Equiva, UniDoc Health Corp., and House RX.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Read about news from Equiva, Healthmine, Prenosis, 9am.health, and Socially Determined.
Check out news from Healthmine, Equiva, NourishedRx and more.
Read about news from Equiva, DNA Script, Healthmine, Infermedica, and more.
Check out news from Equiva, Carrum Health, Healthmine, and more.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Check out new developments from Carrum Health, Health Mine, and more.
Check out new developments from DNA Script, DermBiont, Healthmine, and more.
Check out new developments from Seven Bridges Genomics, Carrum Health, Healthmine, and more.
Read about new developments at Neuroflow, Healthmine, Breakout Ventures and more.
Read news from PromptHealth, HealthMine, Health2047, Sound Life Sciences, and more.